Selenium and vitamin E cancer prevention trial

Annals of the New York Academy of Sciences

Volumn 1031, Issue , 2004, Pages 234-241

  Klein, Eric A ^a,b  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Chemoprevention; Prostate cancer; Selenium; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; MULTIVITAMIN; PLACEBO; PROSTATE SPECIFIC ANTIGEN; SELENIUM; SELENOMETHIONINE;

ADULT; CANCER PREVENTION; CANCER RISK; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHASE 3 CLINICAL TRIAL; PROSTATE BIOPSY; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VITAMIN INTAKE;

EID: 14944338731     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1331.023     Document Type: Conference Paper

References (32)

1. JEMAL, A., R.C. TIWARI, T. MURRAY, et al. 2004. Cancer statistics, 2004. CA Cancer J. Clin. 54: 8-29.
2. THOMPSON, I.M., P.J. GOODMAN, C.M. TANGEN, et al. 2003. The influence of finasteride on the development of prostate cancer. N. Engl. J. Med. 17: 215-224.
3. HEINONEN, O.P., D. ALBANES, J.K. HUTTUNEN, et al. 1998. Prostate cancer and supplementation with α-tocopherol and β-carotene: incidence and mortality in a controlled trial. J. Natl. Cancer Inst. 90: 440-446.
4. CLARK, L.C., G.F. COMBS, JR., B.W. TURNBULL, et al. 1996. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial. Nutritional Prevention of Cancer Study Group. J. Am. Med. Assoc. 276: 1957-1963.
5. KLEIN, E.A. 2004. Selenium: epidemiology and basic science. J. Urol. 171: S50-S53.
6. DONG, Y., H. ZHANG, L. HAWTHORNE, et al. 2003. Delineation of the molecular basis for Se-induced growth arrest in human prostate cancer cells by oligonucleotide array. Cancer Res. 63: 52-59.
7. ZHAO, H., M.L. WHITFIELD, T. XU, et al. 2003. Diverse effects of methylseleninic acid on the transcriptional program of human prostate cancer cells. Mol. Biol. Cell. [Nov. 14 Epub, ahead of print.]
8. ZU, K & C. IP. 2003. Synergy between selenium and vitamin E in apoptosis induction is associated with activation of distinctive initiator caspases in human prostate cancer cells. Cancer Res. 63: 6988-6995.
9. WATERS, D.J., S. SHEN, D.M. COOLEY, et al. 2003. Effects of dietary Se supplementation on DNA damage and apoptosis in canine prostate. J. Natl. Cancer Inst. 95: 237-241.
10. GIANDUZZO, T.R., E.G. HOLMES, U. TINGGI, et al. 2003. Prostatic and peripheral blood selenium levels after oral supplementation. J. Urol. 170: 870-873.
11. YOSHIZAWA, K., W.C. WILLETT, S.J. MORRIS, et al. 1998. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J. Natl. Cancer Inst. 90: 1219-1224.
12. LI, J.Y., P.R. TAYLOR, B. LI, et al. 1993. Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J. Natl. Cancer Inst. 85: 1492-1498.
13. DUFFIELD-LILLICO, A.J., B.L. DALKIN, M.E. REID, et al. 2003. Se supplementation, baseline plasma Se status, and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Study Group. Br. J. Urol. Intl. 91: 608-612.
14. BURTON, G.W. & K.U. INGOLD. 1981. Autoxidation of biological molecules. 1. The antioxidant activity of vitamin E and related chain-breaking phenolic antioxidants in vitro. J. Am. Chem. Soc. 103: 6472.
15. MACHLIN, L.J. 1991. Vitamin E. In Handbook of Vitamins. 2nd edit. L.J. Machlin, Ed.: 67-83. Marcel Dekker. New York, NY.
16. PAPPAS, A.M. 1998. Vitamin E: Tocopherols and Tocotrienols. In Antioxidant Status, Diet, Nutrition, and Health. A.M. Pappas, Ed.: 460-478. CRC Press. Boca Raton, FL.
17. AZZI, A., D. BOSCOBOINIK, D. MARILLEY, et al. 1995. Vitamin E: a sensor and an information transducer of the cell oxidation state. Am. J. Clin. Nutr. 62: 1337s-1346s.
18. MAHONEY, C.W. & A. AZZI. 1988. Vitamin E inhibits protein kinase C activity. Biochem. Biophys. Res. Commun. 154: 694-697.
19. CHATELAIN, E., D.O. BOSCOBOINIK, G.M. BARTOLI, et al. 1993. Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. Biochim. Biophys. Acta 1176: 83-89.
20. OTTINO, P. & J.R. DUNCAN. 1997. Effect of alpha-tocopherol succinate on free radical and lipid peroxidation levels in BL6 melanoma cells. Free Radic. Biol. Med. 22: 1145-1151.
21. NI, J., M. CHEN, Y. ZHANG, et al. 2003. Vitamin E succinate inhibits human prostate cancer cell growth via modulating cell cycle regulatory machinery. Biochem. Biophys. Res. Commun. 300: 357-363.
22. THOMPSON, T.A. & G. WILDING. 2003. Androgen antagonist activity by the antioxidant moiety of vitamin E, 2,2,5,7,8-pentamethyl-6-chromanol in human prostate carcinoma cells. Mol. Cancer Then 2: 797-803.
23. DOLL, R. & R. PETO. 1981. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States. J. Natl. Cancer Inst. 66: 1192-1308.
24. COMSTOCK, G.W., K.J. HELZLSOUER & T.L. BUSH. 1991. Prediagnostic serum levels of carotenoids and vitamin E as related to subsequent cancer in Washington County, Maryland. Am. J. Clin. Nutr. 53: 260S-264S.
25. KNEKT, P., A. AROMAA, J. MAATALA, et al. 1988. Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up. Am. J. Epidemiol. 127: 28-41.
26. HSING, A.W, G.W. COMSTOCK, H. ABBEY & B.F. POLK. 1990. Serologic precursors of cancer: retinol, carotenoids, and tocopherol and risk of prostate cancer. J. Natl. Cancer Inst. 82: 941-946.
27. ATBC CANCER PREVENTION STUDY GROUP. 1994. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 330: 1029-1035
28. VIRTAMO, J., P. PIETINEN, J.K. HUTTUNEN, et al. 2003. ATBC Study Group: incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. J. Am. Med. Assoc. 290: 476-485.
29. GOODMAN, G.E., S. SCHAFFER, G.S. OMENN, et al. 2003. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial. Cancer Epidemiol. Biomarkers Prev. 12: 518-526.
30. HUANG, H.Y., A.J. ALBERG, E.P. NORKUS, et al. 2003. Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am. J. Epidemiol. 157: 335-344.
31. KLEIN, E.A., I.M. THOMPSON, S.M. LIPPMAN, et al. 2003. The Selenium and Vitamin E Cancer Prevention Trial. World J. Urol. 21: 21-27.
32. YUSUF, S., P. SLEIGHT, J. POGUE, et al. 2000. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study. N. Engl. J. Med. 342: 145-153.